0       0

33rd Annual North American Cystic Fibrosis Conference


SC06 - SC06--NRS-CLIN: Taming the Dynamic Duo: Infection & Inflammation


Oct 30, 2019 3:30pm ‐ Oct 30, 2019 7:30pm

Description

The overall goal of this short course is to provide clinicians with knowledge and skills to provide advanced therapy for treatment of CF infection and inflammation. The course will utilize lecture, interactive discussion, and case-based formats. 

The following topics will be addressed: 

  1. Treatment of Pseudomonal and Non-Pseudomonal Pulmonary Infections with Inhaled antibiotics
  2. Reducing Inflammation in CF Lungs, current and future strategies.

Learning Objectives:

  • Describe inhaled therapies prescribed to treat CF Pulmonary Exacerbations caused by Pseudomonas.
  • Formulate management strategies for treatment of sino-pulmonary exacerbations caused by non-Pseudomonas pathogens.
  • Identify therapies targeting CF lung inflammation and discuss the risks and benefits associated with the use of steroids in patients with CF.

    Short Course Leader(s):

    Short Course Speaker(s):

    • Ajai A. Dandekar, M.D., Ph.D., Assistant Professor of Medicine, University of Washington
    • Richard B Moss, M.D., Professor Emeritus Pediatrics, Stanford University Medical Center
    • Eva Cho, B.Sc. (Pharm), ACPR, Pharmacist

    You must be logged in and own this session in order to post comments.

    Print Certificate
    Review Answers
    Print Transcript
    Completed on: token-completed_on
    Review Answers
    Please select the appropriate credit type:
    /
    test_id: 
    credits: 
    completed on: 
    rendered in: 
    * - Indicates answer is required.
    token-content
    token-speaker-name image
    token-speaker-name
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    /
    /
    token-index
    token-content